National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 14120 [2016-05966]
Download as PDF
<![CDATA[
14120
Federal Register / Vol. 81, No. 51 / Wednesday, March 16, 2016 / Notices
Dated: March 11, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel.
Date: March 31, 2016.
Time: 12:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3F100, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3F40A, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5035,
robert.unfer@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: April 12, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3F100, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Uday K. Shankar, Ph.D.,
MSC, Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room #3G21B, National Institutes
of Health, NIAID, 5601 Fishers Lane, MSC
9823, Bethesda, MD 20892–9823, (240) 669–
5051, uday.shankar@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
18:11 Mar 15, 2016
Jkt 238001
[FR Doc. 2016–05966 Filed 3–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, March
31, 2016, 1:00 p.m. to March 31, 2016,
3:00 p.m., National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD
20892 which was published in the
Federal Register on March 10, 2016, 81
FR 12744.
The meeting will be held on April 14,
2016. The meeting time and location
remain the same. The meeting is closed
to the public.
Dated: March 11, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05964 Filed 3–15–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0053]
Agency Information Collection
Activities: Accreditation of Commercial
Testing Laboratories and Approval of
Commercial Gaugers
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: 60-Day Notice and request for
comments; extension of an existing
collection of information.
AGENCY:
U.S. Customs and Border
Protection (CBP) of the Department of
Homeland Security will be submitting
the following information collection
request to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act: Accreditation of
Commercial Testing Laboratories and
Approval of Commercial Gaugers. CBP
is proposing that this information
collection be extended with no change
to the burden hours or to the
information collected. This document is
SUMMARY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
published to obtain comments from the
public and affected agencies.
DATES: Written comments should be
received on or before May 16, 2016 to
be assured of consideration.
ADDRESSES: Written comments may be
mailed to U.S. Customs and Border
Protection, Attn: Tracey Denning,
Regulations and Rulings, Office of
International Trade, 90 K Street NE.,
10th Floor, Washington, DC 20229–
1177.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to Tracey Denning,
U.S. Customs and Border Protection,
Regulations and Rulings, Office of
International Trade, 90 K Street NE.,
10th Floor, Washington, DC 20229–
1177, at 202–325–0265.
SUPPLEMENTARY INFORMATION: CBP
invites the general public and other
Federal agencies to comment on
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (Pub. L. 104–13).
The comments should address: (a)
Whether the collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimates of the burden of the
collection of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; (d)
ways to minimize the burden including
the use of automated collection
techniques or the use of other forms of
information technology; and (e) the
annual cost burden to respondents or
record keepers from the collection of
information (total capital/startup costs
and operations and maintenance costs).
The comments that are submitted will
be summarized and included in the CBP
request for OMB approval. All
comments will become a matter of
public record. In this document, CBP is
soliciting comments concerning the
following information collection:
Title: Accreditation of Commercial
Testing Laboratories and Approval of
Commercial Gaugers.
OMB Number: 1651–0053.
Form Number: Form 6478.
Abstract: Commercial laboratories
seeking accreditation or approval must
provide the information specified in 19
CFR 151.12 to Customs and Border
Protection (CBP), and Commercial
Gaugers seeking CBP approval must
provide the information specified under
19 CFR 151.13. This information may be
submitted on CBP Form 6478. After the
initial approval and/or accreditation, a
private company may ‘‘extend’’ its
approval and/or accreditation to add
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 81, Number 51 (Wednesday, March 16, 2016)]
[Notices]
[Page 14120]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05966]
[[Page 14120]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel.
Date: March 31, 2016.
Time: 12:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3F100, 5601 Fishers
Lane, Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Robert C. Unfer, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3F40A, National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5035,
robert.unfer@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: April 12, 2016.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3F100, 5601 Fishers
Lane, Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Uday K. Shankar, Ph.D., MSC, Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room #3G21B, National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5051,
uday.shankar@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 11, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-05966 Filed 3-15-16; 8:45 am]
BILLING CODE 4140-01-P
